Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-03-27-Speech-4-010"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2003-03-27"^^xsd:date2
dcterms:Is Part Of	lp_eu:Combating HIV/AIDS, malaria and tuberculosis in developing countries2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20030327.1.4-010"2
lpv:hasSubsequent	lp_eu:2003-03-27-Speech-4-0112
lpv:speaker	lp:Francesco Fiori2
lpv:spokenAs	substitute; Committee on Industry, External Trade, Research and Energy (2002-01-17--2004-07-19)3 member; AGRI (2002-01-17--2004-07-19)3 member; Delegation for relations with the countries of South America and MERCOSUR (2002-02-07--2004-07-19)3 unknown; Forza Italia (1999-07-20--2004-07-19)3 vice-chair; EPP-ED (1999-09-30--2004-07-19)3
lpv:translated text	"Mr President, Commissioner, congratulations to the rapporteur, Mr Caudron, for the excellent results attained on a programme which, rhetoric apart, can truly be defined as a real challenge for civilisation so to speak, equality between the northern and southern hemispheres. Moreover, the best aspect of this work is that the Commission’s proposal is an unprecedented innovation in that, although Article 169 is an excellent formulation, it is being applied in practice for the first time, and, by taking this line, we are creating a genuine, tangible partnership to address a real problem concerning the northern and southern hemispheres. This initiative is so astute that it should be repeated in both the research sector and other key areas of the Union’s foreign relations. Since I agree with the position set out by the rapporteur, I will make three very brief remarks. Firstly, I think that it was a positive decision not to extend the programme to related diseases, not because they are less important, but because we should not disperse our resources and efforts. Moreover, the results can be used to improve the treatment of other diseases and can form the basis of new research activities, thereby contributing to resolving other health issues related to the problems experienced by developing countries. Secondly, regarding Amendment No 13 – involvement of the private sector – I believe that it is particularly important to involve the private sector in the programme because this will enable additional funds to be leveraged, encouraging businesses to invest more in diseases which affect developing countries. In this connection, a debate on tax differentiation mechanisms could be an extremely interesting incentive. The third point concerns the protection of intellectual property. Involvement of the pharmaceutical industry is essential for the success of the programme. We must have differentiated pricing for medicines sold in developing countries and, in my opinion, we need different labels as well to prevent fraud."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph